Glenmark Pharmaceuticals has received final USFDA approval for generic version of Strattera capsules, used in the treatment of attention-deficit/hyperactivity disorder (ADHD). The company has been […]
Zydus Cadila has received final USFDA approval to market Felbamate tablets, used to treat seizures in people with epilepsy, in the American market. The company […]
Zydus Cadila has received final USFDA approval to market antihistamine Cyproheptadine Hydrochloride tablets in the US market. The tablets are used to relieve allergy symptoms […]
Zydus Cadila has received approval from USFDA to market mesalamine tablets used for the treatment of ulcerative colitis. The US FDA has given its final […]
Zydus Cadila has received USFDA approval to market Mirtazapine orally disintegrating tablets, an anti depressant, in the US market. The drug will be marketed in […]
Zydus Cadila has received final USFDA approval to market Doxazosin tablets, used for treatment of high blood pressure and urinary retention associated with enlargement of […]
Jubilant Life Sciences through its subsidiary has received final USFDA approval for Bupropion Hydrochloride extended-release tablets, used for the treatment of major depressive disorder and […]
Zydus Cadila has received final USFDA approval to market Acylovir drug for injection USP in strengths of 500 mg/vial and 1000 mg/vial. The drug is […]
Glenmark Pharmaceuticals has received final USFDA approval for its generic version of anti-inflammatory drug Indomethacin tablets. The drug is the generic equivalent of Indocin SR […]
Zydus Cadila has received final USFDA approval to market oxybutynin chloride tablets in USA. The drug is used to treat overactive bladder and urinary incontinence […]
Copyright © 2024 | WordPress Theme by MH Themes